KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of Product SalesDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitOpex As A % Of Total Revenue %OPEX SegregationProperty And EquipmentRevenue By Category Contract Revenue From CollaborationsRevenue By Category Contract Revenue From Collaborations AnnualRevenue By Collaborative Partners AnnualRevenue By Major CustomersRevenue By Major Customers %Revenue By Major Customers AnnualRevenue By Major Customers Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Bottles ShippedTotal Bottles Shipped Annual
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Rigel Pharmaceuticals (RIGL) Gross Profit (2018 - 2026)

Rigel Pharmaceuticals' quarterly Gross Profit came in at $54.2 million in Q1 2026, up 10.81% year-on-year from $48.9 million in Q1 2025, and down 15.09% quarter-over-quarter from $63.8 million in Q4 2025.

Rigel Pharmaceuticals has reported Gross Profit for 9 years, with the latest figure at $54.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Gross Profit rose 10.81% year-over-year to $54.2 million; the trailing twelve-month figure through Mar 2026 stood at $279.9 million (up 53.78% YoY), and the FY2025 full-year result was $274.7 million, up 70.99% from the prior year.
  • Gross Profit for Q1 2026 stood at $54.2 million, down from $63.8 million in the prior quarter.
  • The five-year high for Gross Profit was $97.2 million in Q2 2025, with the low at $16.6 million in Q1 2022.
  • Average Gross Profit over 5 years is $42.2 million, with a median of $34.0 million recorded in 2024.
  • Year-over-year, Gross Profit plunged 79.41% in 2022 and soared 185.54% in 2025.
  • Tracing RIGL's Gross Profit over 5 years: stood at $50.9 million in 2022, then tumbled by 37.17% to $32.0 million in 2023, then jumped by 61.89% to $51.8 million in 2024, then rose by 23.24% to $63.8 million in 2025, then retreated by 15.09% to $54.2 million in 2026.
  • The last three Gross Profit figures came in at $54.2 million (Q1 2026), $63.8 million (Q4 2025), and $64.7 million (Q3 2025), per Business Quant data.